A bill to reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
Summary
S. 4189 is a Senate bill introduced by Senator Jeanne Shaheen (D-NH) that would address insulin affordability and patient protections. The bill aims to reduce the price of insulin, a critical medication for people with diabetes, and establish safeguards to protect patients from high out-of-pocket costs related to insulin. If enacted, the legislation could help make insulin more accessible and affordable for Americans who depend on this medication. The bill is currently in the committee review process and has not yet been voted on by the full Senate.
AI-generated summary
Lifecycle of the Bill
Introduced in Senate
Mar 25, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 25, 2026